Senti Biosciences Inc (SNTI)
0.3401
-0.01
(-3.11%)
USD |
NASDAQ |
May 24, 16:00
0.3465
+0.01
(+1.88%)
After-Hours: 20:00
Senti Biosciences Shareholders Equity (Quarterly): 56.09M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 56.09M |
December 31, 2023 | 66.91M |
September 30, 2023 | 82.94M |
June 30, 2023 | 97.42M |
March 31, 2023 | 112.34M |
Date | Value |
---|---|
December 31, 2022 | 127.26M |
September 30, 2022 | 140.34M |
June 30, 2022 | 154.27M |
December 31, 2021 | -111.46M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-111.46M
Minimum
Dec 2021
154.27M
Maximum
Jun 2022
80.68M
Average
97.42M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
iBio Inc | 24.86M |
Theriva Biologics Inc | 34.12M |
Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 102.18M |
Total Liabilities (Quarterly) | 46.09M |